retatrutide osteoarthritis Guide 2023: Weight Loss, Benefits, Results, Dosage Lilly's triple agonist, retatrutide, drove
Description
6 June 2026 Peer-reviewed TRANSCEND-T2D-1 Phase 3 diabetes results are published online by The Lancet
Supplementary information The online version contains supplementary material available at 10.1038/s41421-024-00700-0
References 1.Ong K.L., Stafford L.K., McLaughlin S.A., et al
Yu H, Rimbert A, Palmer AE, Toyohara T, Xia Y, Xia F, et al
